U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

The FDA has approved Cobenfy, a new schizophrenia medication by Bristol Myers Squibb, marking the first novel treatment in decades. Unlike traditional drugs, Cobenfy targets neurotransmitters ...

While diet alone probably isn’t enough to cause GERD ... Eating right before you go to sleep can also be problematic, ...

FDA alerts in gastroenterology over the summer included an approval for a biosimilar for IBD & new indications for nonerosive ...

Phathom Pharmaceuticals developed Voquezna, a first-in-class PCAB, licensed from Takeda, for acid-related disorders. Find out ...

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

Bristol-Myers Squibb (BMY) stock rises as FDA approves Cobenfy as a ovel treatment for adults with the psychiatric disorder ...

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

Gastroesophageal reflux disorder (GORD), or gastroesophageal reflux disease (GERD), can significantly impact oral health, ...

My husband has late-stage stomach cancer, and we’ve heard there’s a new treatment for it, something called HIPEC. What is ...

Low-lactose diet for bloating and gas due to lactose intolerance Low FODMAP diet for irritable bowel syndrome High-fiber ...

Researchers found that using real food from grocery stores instead of allergen extracts helped expedite sublingual ...